Abstract
Introduction
Leishmaniasis is a group of diseases caused by several species of the genus Leishmania. It has been estimated that 1.5 million new cases of Cutaneous Leishmaniasis occur annually and more than 80.0% of the total cases affect individuals in developing countries. Brazil, Iran, Afghanistan and Sudan suffer the highest prevalence and the disease is a priority for public health in all hyper endemic regions of the world 1 . Human Leishmaniasis is usually classified as Cutaneous and visceral or old world type and new world type 1 1 . It is transmitted by the bite of female sand fly of the genera Phlebotomus in Old world, Lutzomyia and Psychodopygus in the new world. Almost all of the Cutaneous Leishmaniasis passes through common stages of papule and nodule formation, central crusting, ulceration and healing with scar formation 1 . In many instances a simple test like demonstration of Amastigotes in Giemsa-stained smears from infected skin by direct microscopy can easily confirm the diagnosis. Both systemic as well as local treatments are helpful. In Bangladesh although kala azar is common, few cases of Cutaneous Leishmaniasis was documented 2 3 . Here we report a case of Cutaneous Leishmaniasis, who was successfully treated with intramuscular injection of sodium stibogluconate.
Case report
A 37-year-old normotensive, non diabetic Muslim male had been working in Saudi Arabia for more than 15 years returned to Bangladesh with the complaint of multiple ulcerated skin lesion for last three months. He at first noticed some nodules which subsequently became ulcerated. He gave no history of fever, cough or any other symptoms.
On examination the ulcers were seen on nasal bridge, right ear lobule and dorsum of right ring finger. Ulcers were mildly tender, reddish, deep, crusted, 3-4 cm in diameter with no discharge. His vital parameters were normal, no nerve thickening, lymphadenopathy or organomegaly were found. Other systemic examinations were unremarkable.
lymphocyte-21%, RBS-80 mg/dl, S.Creatinine-0.8 mg/ dl, SGPT-25 IU/L, ECG, CXR, Urine RME were within normal limit. Anti HIV antibody was negative. Biopsy from the skin lesion confirmed the diagnosis of Cutaneous Leishmaniasis evidenced by the presence of intra and extra cellular LD bodies.
We treated the patient with sodium stibogluconate 1200mg intramuscular injection for 28 days without having any complications. After 2 weeks of treatment the ulcers gradually started to heal. We did slit skin smear on day 22 and day 29 and no LD body was seen.
Discussion
Leishmaniasis is a major world health problem. The disease is endemic in 88 countries. Brazil, Iran, Afghanistan and Sudan suffer the highest prevalence. It is caused by protozoa Leishmania. It may produce a variety of clinical syndromes varying from a simple ulcer to fatal systemic disease. Infection is transmitted by the bite of the sand fly, usually at night and outdoors. It is imported into non-endemic countries by immigrants and returning travelers as in our patient. Incubation period may range from few days to over a year. All previously uninfected individuals are susceptible for Cutaneous Leishmaniasis. One or more lesions occur in unclothed parts of the body as in our case. Clinical stages pass from papule, nodule, crusting, ulceration and finally healing with scarring. Our case presented with non healing ulcer which had started as papule subsequently progressed towards nodule formation, crusting and ulceration. Diagnosis of Cutaneous Leishmaniasis can be confirmed by demonstration of Amastigotes in Giemsa stained smears from infected skin by direct microscopy, intracellular Amastigotes in the dermis of H&E (Haematoxylin and Eosin) stained sections from biopsy specimen, presence of Leishmania granulomas in the dermis in H&E specimens, growth of promastigotes in Nicolle-Novy-McNeal (NNN) culture medium from lesional specimens and demonstration of Leishmania DNA by PCR. The clinical diagnosis is not difficult with typical clinical features in the endemic region. Most sores heal spontaneously, but their duration cannot be predicted in an individual case. Various therapeutic modalities have been used for treating Cutaneous Leishmaniasis. Intralesional pentavalent antimonials injection is one of the effective therapeutic modalities. Topical methods of treatment can be tried for simple sores. Alternate day or weekly intralesional treatment of Cutaneous Leishmaniasis with sodium stibogluconate has been shown to be more effective than daily treatments 5 . Uzun S et al, have shown the efficacy of intralesional sodium stibogluconate to be 97.2% with a low relapse rate of 3.9% and no serious adverse side effects 6 . However some studies have shown combination of cryotherapy with intralesional injections of sodium stibogluconate, much more effective than the use of intralesional sodium stibogluconate alone 7 . Systemic treatment with pentavalent antimonials is indicated for problematic sores like involvement of mucosa or cartilage, sores on the lower leg or over a joint, sores where scarring would be disabling or disfiguring and sores that might be due to parasites of the L.brasiliensis group. L. aethiopica is only sensitive to Pentamidine. Hence species characterization is also an important aspect of management. Antimonials are still the first line drug in the treatment of Cutaneous Leishmaniasis. Sodium stibogluconate (Pentostam) and meglumine antimonite (Glucantime) are essentially similar drugs which contain pentavalent antimony (Sb). Sodium stibogluconate can be administered intravenously or intramuscularly, while meglumine antimonate should only be given via the intramuscular route. The recommended dose is 20 mg/kg/day for 15 -20 days 8 . Treatment with antimonials is associated with some side effects such as myalgia, as well as possible liver or cardiovascular toxicity, which fortunately is rare.
A recent study using intralesional sodium stibogluconate showed that alternate day or weekly administration of intralesional sodium stibogluconate was effective in the treatment of Cutaneous Leishmaniasis 5 . Nevertheless, in our case, we were not able to identify the species due to lack of facilities for DNA analysis, hence managed successfully with intramuscular injection of sodium stibogluconate.
Conclusion
Although Cutaneous Leishmaniasis is rare in Bangladesh, clinicians should be aware of the disease while treating non healing ulcers of long duration especially if the patient is an immigrant from endemic areas.
